Eric Ribner

Biotech Investor Relations Pro | Ex-Hedge Fund Analyst | Connector to 800+ High Net Worth Investors | Columbia MBA | Passionate Musician & Carpenter

[Eric Ribner @eribner]

@drawingsymbols Nope

[Eric Ribner @eribner]

I’m hosting $INBX CEO for a zoom call on Wednesday at 1 pm est. If you want to join, email me at [email protected]

[LifeSci Advisors @LifeSciAdvisors]

Join LifeSci Advisors tomorrow, Dec. 16 at 1pm ET for our virtual webinar series, “Lunch with LifeSci” featuring @Quince_Tx $QNCX, a late-stage rare-disease biotech company nearing a major catalyst with Phase 3 data expected in Q1 2026.

Register: https://t.co/WqTvpcniY1

[Eric Ribner @eribner]

$LENZ Received my first full month of #Vizz after finishing a 5-day sample from my eye doctor. Side effects fade fast—redness gone in 10 min, no headache, and vision great even in dim light. Typing this on my phone without readers. Great product—just give your eyes time to adjust

[Eric Ribner @eribner]

@TheBio_Hunter …that’s not my experience after using Vizz. Redness clears up after 15 minutes and the headache has lessoned with each passing day of use. The ability to read my phone, a menu, a magazine without my readers is worth it!

[LifeSci Advisors @LifeSciAdvisors]

Join us for our “Lunch with LifeSci” series on Aug. 27 at 12pm ET with LENZ Therapeutics $LENZ, fresh off FDA approval of VIZZ™, the first and only aceclidine-based, once-daily eye drop designed to restore near vision for the full workday.

Register: https://t.co/kOls592Vlf

[Eric Ribner @eribner]

https://t.co/gyxXZdXMyF

[LifeSci Advisors @LifeSciAdvisors]

Join us on Monday, April 7 at 12pm ET for the "Lunch with LifeSci" with @AuraBiosciences $AURA. CEO Elisabet de los Pinos and CMO Jill Hopkins will share insights into the company’s latest advancements in ocular and bladder cancer treatments. Register: https://t.co/5D7qE7PTGn

[Eric Ribner @eribner]

@LifeSciAdvisors Take an hour on April 7th to hear me interview the CEO of $Aura Bio and learn how they use near-infrared light to activate their cancer-killing drug. Very cool and promising technology! Register using the link below.

[LifeSci Advisors @LifeSciAdvisors]

Join us on Monday, April 7 at 12pm ET for the "Lunch with LifeSci" with @AuraBiosciences $AURA. CEO Elisabet de los Pinos and CMO Jill Hopkins will share insights into the company’s latest advancements in ocular and bladder cancer treatments. Register: https://t.co/5D7qE7PTGn

[Eric Ribner @eribner]

@mlazaru @ByMadeleineA I’m hosting a webinar today at 12:30 est w CEO OF $cmpx…find out how far they are! Register here: https://t.co/kwluOQlk0y

[Eric Ribner @eribner]

Register to listen to my interview of Abivax ($ABVX) management on Oct 22 at 12 pm ET to learn about their novel oral therapy currently in Phase 3 for ulcerative colitis (UC) and entering Phase 2 trials for Crohn’s disease (CD), a multi-billion dollar market.

[LifeSci Advisors @LifeSciAdvisors]

Join us on Tues, Oct. 22 at 12pm ET for the latest in our "Lunch with LifeSci" series with @Abivax_ $ABVX, featuring CEO, Marc de Garidel and CFO, Didier Blondel to discuss the growing need for new safe and durable treatments for IBD. Register: https://t.co/MOdsAeIap7

[Eric Ribner @eribner]

Register to listen in on Wednesday Aug 14th at 12 pm ET to learn about $VERA’s very promising IgA Nephropathy drug. I’ll be interviewing the CEO about their solution to this terrible kidney disease effecting 120k people in the US. Hope to spend the lunch hour with you over zoom!

[LifeSci Advisors @LifeSciAdvisors]

Join us next Wednesday, August 14th at 12pm ET for the latest in our exclusive webinar series, “Lunch with LifeSci featuring @Official_VeraTx” where we will interview Dr. Marshall Fordyce, Founder and CEO, and Sean Grant CFO. Register: https://t.co/oE7oWF9KhU

[LifeSci Advisors @LifeSciAdvisors]

Join us this Wednesday, June 26 at 1pm ET for "Lunch with LifeSci" featuring @Ligand_LGND, where we will interview CEO Todd Davis to get an inside look at the biopharmaceutical royalty aggregator and its impressive portfolio. Register now: https://t.co/DptXRGTeME

[Eric Ribner @eribner]

Please Join me tomorrow, Feb 20th at 1 pm est when I interview Rob Berman, CEO of enVVeno. We'll be talking about CVI, the VenoValve's road to approval, and putting their upcoming pivotal trial readout into context. Please register here: https://t.co/HMcapEvGwW

[Eric Ribner @eribner]

I’m moderating a call with 3 of my colleagues on Friday, Dec 8th at 12 pm est. Zoom in to our conversation about the current state of biotech and opportunities in 2024.

https://t.co/PXVFzmPn1K

[LifeSci Advisors @LifeSciAdvisors]

Join us on Fri. Dec 8th at 12pm ET for the virtual Lunch with LifeSci series, featuring Mark Charest, PhD, Paul Yook and Hany Awadalla, who will discuss where they see opportunity today, after 3 years of negative returns for the biotech sector.
Register: https://t.co/lVq4gr405E

[LifeSci Advisors @LifeSciAdvisors]

Join us on Oct 3rd at 12pm ET with @Moonlaketx ( $MLTX ), featuring Jorge Santos de Silva, CEO, and Matthias Bodenstedt, CFO, to discuss sonelokimab, a next generation IL-17 inhibitor for autoimmune inflammatory diseases.

RSVP: https://t.co/anTyCeZ1mL

[Eric Ribner @eribner]

Register to listen to my interview with Disc Medicine $iron on Sept 14th @ 1 pm est

[LifeSci Advisors @LifeSciAdvisors]

Join us on September 14th at 1pm ET for the virtual Lunch with LifeSci series, featuring @DiscMedicine ( $IRON ), discussing a rare group of blood diseases (EPP & XLP), and Disc Medicine’s investigational, potential treatment, Bitopertin.

RSVP: https://t.co/RcaQAiGaUI

[LifeSci Advisors @LifeSciAdvisors]

Tune in…Lunch with LifeSci featuring Luca Santarelli, CEO of @VectivBio (VECT), a company focusing on SBS-IF. Learn about VECT’s potential treatment solution, apraglutide which improves intestinal absorptive capacity and improves GI function. Register: https://t.co/cuGkPdosPz

[Sahil Bloom @SahilBloom]

Today is my 32nd birthday.

Over the last month, I asked several 90-year-olds what advice they would give to their 32-year-old selves.

Here's the life advice everyone needs to hear:

[University of Utah Vascular Surgery @UofUVascular]

@UofUVascular 1st patient in the #SAVVE trial w/ 100% healing of venous ulcer at 1 month from @enVVenoMedical #venovalve implant by Dr. Claire Griffin! Advancing vein care through innovation. @VenousForum